EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Predisposition to Male Breast Cancer

Markéta Janatová, Marianna Borecká, Petra Zemánková, Kateřina Matějková, Petr Nehasil, Leona Černá, Marta Černá, Petra Dušková, Taťána Doležalová, Lenka Foretová, Ondřej Havránek, Jana Házová und 26 weitere

Folia Biologica · 2024

DOI: 10.14712/fb2024070050274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Biologica, 2024. Verfasst von Markéta Janatová und 37 weiteren Autor:innen. Beteiligte Einrichtung: CZECANCA consortium, Czech Republic. mjana@lf1.cuni.cz. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease, Breast Neoplasms, Male. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstvo Zdravotnictví Ceské Republiky, Ministerstvo Školství, Mládeže a Tělovýchovy, Univerzita Karlova v Praze.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Male breast cancer (mBC) is a rare cancer diagnosis that constitutes less than 1 % of all breast cancer cases globally. Genetic factors play an important role in the mBC risk. Germline pathogenic variants (PVs) in cancer predisposition genes could be identified in about 15 % of cases. We performed germline genetic testing in 248 Czech mBC patients and 3,626 non-cancer male controls using next-generation sequencing by the CZECANCA panel (226 genes). We identified 46/248 (18.5 %) carriers of PVs in the established mBC predisposition genes, primarily in BRCA2 (N = 34), less frequently in BRCA1 (N = 7) and PALB2 (N = 5). The presence of a PV in these genes significantly increased the mBC risk (OR 44.04; 5.82; and 8.26, respectively). Additionally, we identified 16 carriers of PVs in candidate mBC genes, but only PVs in CHEK2 were significantly associated with increased mBC risk (OR = 4.98). The significance of 26 germline alterations in 23/192 additionally analysed genes remained uncertain. The carriers of PVs in BRCA1 and CHEK2 were significantly younger (55.8 and 52.6 years, respectively) than non-carriers (64.8 years), and all carriers of PVs in the established genes had more frequently grade G3 tumours and positive family cancer history. Our study underscores the critical role of BRCA2 in mBC predisposition while also highlighting the potential contributions of additional genes that warrant further investigation. Moreover, it supports and justifies universal genetic testing for all mBC patients to generally improve early cancer detection and tailored treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Predisposition to DiseaseBreast Neoplasms, MaleHumansMaleMiddle AgedGerm-Line MutationAdultAgedCheckpoint Kinase 2Genetic TestingBRCA2 ProteinBRCA1 Protein

Stichwörter der Autor:innen

NGSgermline genetic testinghereditary cancer predispositionmale breast cancer

Substanzen

CHEK2 protein, humanCheckpoint Kinase 2BRCA2 ProteinBRCA1 Protein

Autor:innen und Institutionen

  • CZECANCA consortium, Czech Republic. mjana@lf1.cuni.cz.
  • Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. mjana@lf1.cuni.cz.
  • CZECANCA consortium, Czech Republic.
  • Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Department of Genetics and Microbiology, Faculty of Science, Charles University, Prague, Czech Republic.

Förderung

  • Ministerstvo Zdravotnictví Ceské Republiky
  • Ministerstvo Školství, Mládeže a Tělovýchovy
  • Univerzita Karlova v Praze

Zitieren

APA

Janatová, M., Borecká, M., Zemánková, P., Matějková, K., Nehasil, P., Černá, L., Černá, M., Dušková, P., Doležalová, T., Foretová, L., Havránek, O., Házová, J., Horáčková, K., Hovhannisyan, M., Hrušková, L., Chvojka, Š., Janíková, M., Kalousová, M., Kosařová, M., …, & Kleibl, Z. (2024). Genetic Predisposition to Male Breast Cancer. Folia Biologica. https://doi.org/10.14712/fb2024070050274

Vancouver

Janatová M, Borecká M, Zemánková P, Matějková K, Nehasil P, Černá L, et al. Genetic Predisposition to Male Breast Cancer. Folia Biologica. 2024. doi:10.14712/fb2024070050274

BibTeX
@article{Janatov2024,
  author = {Janatová, Markéta and Borecká, Marianna and Zemánková, Petra and Matějková, Kateřina and Nehasil, Petr and Černá, Leona and Černá, Marta and Dušková, Petra and Doležalová, Taťána and Foretová, Lenka and Havránek, Ondřej and Házová, Jana and Horáčková, Klára and Hovhannisyan, Milena and Hrušková, Lucie and Chvojka, Štěpán and Janíková, Mária and Kalousová, Marta and Kosařová, Marcela and Koudová, Monika and Krhutová, Veronika and Krulišová, Veronika and Macháčková, Eva and Michalovská, Renáta and Němcová, Barbora and Novotný, Jan and Šafaříková, Markéta and Šťastná, Barbora and Stránecký, Viktor and Šubrt, Ivan and Tavandzis, Spiros and Vlčková, Zdeňka and Vočka, Michal and Vrtěl, Radek and Zima, Tomáš and Soukupová, Jana and Kleiblová, Petra and Kleibl, Zdeněk},
  title = {Genetic Predisposition to Male Breast Cancer},
  journal = {Folia Biologica},
  year = {2024},
  doi = {10.14712/fb2024070050274}
}
Kostenlos starten →